Compare LyondellBasell Industries NV (LYB) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LyondellBasell Industries NV vs Novavax Inc — how do they compare? LyondellBasell Industries NV trades at $63.98 (market cap $20.67B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: LyondellBasell Industries NV is far larger — about 15.8× Novavax Inc's market cap, and LyondellBasell Industries NV pays a 6.44% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| LYB | NVAX | |
|---|---|---|
Market Cap | $20.67B | $1.31B |
Sector | Basic Materials | Health |
52-Week High | $82.38 | $11.19 |
52-Week Low | $42.28 | $6.22 |
Enterprise Value | $32.26B | $889.30M |
Dividend Yield | 6.44% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About LyondellBasell Industries NV
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
